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Composed of type I and III collagens, the valve leaflets, 
chordae tendineae and collagen matrix of the myocardium 
form a structural continuum. Synthesized by cardiac fibro- 
blasts, these fibrillar collagens support and tether myocytes 
to maintain their alignment, whereas their respective ten- 
sile strength and resilience resist the deformation, maintain 
the shape and thickness, prevent the rupture and contrib- 
ute to the passive and active stiffness of the myocardium. 
An acquired or congenital defect in this collagen network 
can lead to abnormalities in myocardial architecture, me- 
chanics or valve function. In the hypertrophic process that 
accompanies a pressure overload, for example, increased 
collagen synthesis, fibroblast proliferation and a structural 
and biochemical remodeling of the matrix are seen. This 
includes distinctive patterns of reparative and reactive 
myocardial fibrosis, each of which alters diastolic and 
systolic myocardial stiffness and may lead to pathologic 
This article is dedicated to Thomas F. Robinson, PhD 
(1944-1988)--dedicated and creative scientist, respected col- 
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The heart is a muscular pump composed of cardiac myocytes 
(1). In recent years, however, it has been recognized that, 
whereas cardiac myocytes and the coronary vasculature are 
central to the contractile function and viability of the myo- 
cardium, so too is the extracellular matrix, or cardiac 
interstitium, and its type I and III fibrillar collagen matrix in 
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hypertrophy. Alternatively, a loss of collagen tethers or 
decline in matrix tensile strength can be responsible for 
regional or global transformations in myocardial architec- 
ture and function seen in the reperfused (“stunned”) 
myocardium and in dilated (idiopathic) cardiopathy. Inher- 
ited disorders in the transcriptional and posttranslational 
processing of collagen can also alter the biophysical prop 
erties of the network. 
Future studies into collagen gene regulation, gene 
switching events and the control of collagen synthesis and 
degradation are needed to develop a more complete under- 
standing of the relation between the collagen network and 
acquired and inherited forms of heart disease and to utilize 
therapeutics that will prevent, retard or regress abnormal 
collagen matrix remodeling. 
(J Am Co11 Cardiol1989;13:1637-52) 
particular. Collagen fibers, the major structural protein of 
the interstitium, serve several functions: 1) they provide a 
scaffolding that supports muscle cells and blood vessels (2); 
2) they act as lateral connections between cells and muscle 
bundles to govern architecture (2,3) while coordinating the 
delivery of force, generated by myocytes, to the ventricular 
chamber (4); and 3) their respective tensile strength and 
resilience (5) are important determinants of diastolic and 
This article is part of a series of informal teaching reviews 
devoted to subjects in basic cardiology that ure of particular 
interest because of their high potential for clinical applica- 
tion. The intent of the series is to help the clinician keep 
abreast of important advances in our understanding of the 
basic mechanisms underlying normal and abnormal cardiac 
function. 
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systolic myocardial stiffness (6,7) and serve to resist myo- 
cardial deformation, maintain shape and wall thickness and 
prevent ventricular aneurysm and rupture (8,9). Less is 
known about other connective tissue elements of the heart 
and a discussion of the cytoskeleton and glycosaminogly- 
cans, for example, is beyond the intent of this review. 
The fibrillar collagen matrix of the heart is an active 
participant in the hypertrophy that accompanies various 
forms of chronic pressure overload (i.e., aortic stenosis and 
renovascular and essential hypertension). Like the hyper- 
trophic remodeling seen in skeletal muscle (IO), where both 
extracellular matrix and muscle cells increase in dimension, 
an accumulation and enhanced dimension of collagen fibers, 
together with their realignment relative to muscle, have been 
observed in left ventricular pressure overload hypertrophy 
(see Ref. 6 for review). Initially, the physical transformation 
of collagen fibers is an adaptive process that facilitates the 
concentric growth of the myocardium and augments its 
generation of force while increasing diastolic stiffness. Sub- 
sequent alterations in the concentration of collagen, the 
proportion of type I and III collagens, or the alignment of 
collagen and muscle fibers, or both, will determine whether 
this adaptation becomes pathologic (6,7). In other circum- 
stances, such as the “stunned” myocardium (11) or dilated 
primary myocardial heart disease (12), a physical or bio- 
chemical abnormality of collagen tethers has been observed, 
each of which may be responsible for the respective regional 
or global transformation in myocardial architecture, includ- 
ing its thinning, impaired contractility and enlargement of 
the ventricular chamber. 
Continued investigation into the remodeling of the extra- 
cellular matrix as well as the control and regulation of 
collagen synthesis and degradation is needed to fully eluci- 
date the role of the collagen network in health and disease. 
Nevertheless, it would appear timely, at this juncture, to 
review our current understanding of the collagen network to 
heighten general awareness of the important potential con- 
tributions of a disorder of fibrillar collagen in various expres- 
sions of cardiovascular disease. This review also suggests 
that such a broader perspective of the myocardium, which 
includes connective tissue, is necessary to develop our 
understanding of the various entities that will come to be 
recognized as interstitial heart disease. Such a perspective 
mandates that in our consideration of the origins of heart 
disease, including the appearance of heart failure and ven- 
tricular arrhythmias, we include acquired and inherited 
disorders of intracellular and extracellular events fundamen- 
tal to synthesis, fiber formation and degradation of collagen. 
Historical Perspective 
In 1907, Holmgren (13) described the extracellular matrix 
and fibrillar collagen that connected skeletal muscle fibers. 
The terms epi-, peri- and endomysium were used by Nagle 
(14) to characterize the various structural components of the 
extracellular matrix in muscle. In 1960, Hort (15) suggested 
that the collagen matrix of the myocardium prevented its 
excess dilation. He further observed that the configuration of 
perimysial fibers was related to the state of ventricular 
distension (i.e., wavy in contraction and stretched with 
dilation) and proposed that the recoil of the network of thin 
collagen fibers that enveloped muscle contributed to dias- 
tolic filling. About the same time, muscle physiologists had 
become interested in the contribution of elastic elements to 
muscle shortening. Modeled as springs that were arranged in 
series or in parallel with contractile element (16,17), these 
elastic elements had no clear anatomic counterpart, although 
they were presumed to be connective tissue. The advent of 
the scanning electron microscope brought the ultrastructural 
nature of the collagen matrix, the major elastic element of 
the myocardium, into perspective (see later). Immunohisto- 
chemical studies and biochemical analysis identified the 
fibrillar collagen matrix as consisting primarily of type I and 
III collagens. 
The fractional volume of collagen in the myocardium is 
small. Its high tensile strength, however, influences myocar- 
dial stiffness, as is the case for any composite material or 
alloy that is composed of various elements, each having 
different elastic constants. The collagen concentration of the 
right ventricle is approximately 30% greater than that of the 
left ventricle (18) because its myocytes are smaller. 
Structure, Function and Metabolism of the 
Normal Collagen Matrix 
The Cardiac Interstitium 
The interstitium of the myocardium includes fibrillar 
connective tissue; various cells, such as fibroblasts and 
plasma cells, and a gel-like ground substance composed of 
glycosaminoglycans and glycoproteins. Cardiac nerves and 
the coronary vasculature also reside in the interstitium. 
Myocytes represent only one-third of the number of cells; 
however, their volume accounts for over two-thirds of the 
myocardium (19). Fibroblasts may represent as much as 
two-thirds of the cells. Type I and III collagens are the 
dominant components of fibrillar connective tissue. Elastin 
is also seen, but to a lesser extent (20). In arteries, on the 
other hand, elastin is present in larger quantities providing a 
resilience to vessels necessary for their cyclical distension. 
The interstitium serves several functions. These include 
1) providing a structure that supports and tethers cardiac 
myocytes, intramyocardial coronary arteries, arterioles, 
capillaries and veins; 2) maintaining a defense mechanism 
against invasion by foreign protein, bacteria or viruses; 3) 
aiding in the nutrition of myocytes, by facilitating the ex- 
change of substrates between myocytes and their capillaries; 
and 4) providing a lubricant for contracting myocytes. In 
keeping with the heart’s known autocrine and paracrine 
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Figure 1. Insertion of the chordae tendineae into the papillary 
muscle (arrow) is shown to arborize into a network of coiled 
perimysial fibers (CPF) that are interconnected by strands (S) of 
collagen. EC = epimysial collagen fibers. (Reproduced with permis- 
sion from Robinson et al. [21].) 
properties, the interstitium will likely be shown to contain 
putative mitogens that mediate cell growth. These mitogens 
will normally reside in or gain entry to the interstitium. In 
this review, we will focus solely on the structural protein, 
collagen and its contribution to the myocardium in health 
and disease. A broader perspective of the cardiac intersti- 
tium is beyond the scope of this review. 
The Collagen Network of the Heart 
The leaflets of the semilunar and atrioventricular (AV) 
valves, together with chordae tendineae and the intramyo- 
cardial collagen matrix, form a structural continuum (Fig. I) 
that represents the collagen network of the heart (21). A 
biochemical defect (22) within this collagenous network or 
its physical interruption (23) has the potential to adversely 
alter its tensile strength and tethering-support function and 
thereby alter the architecture and mechanical properties of 
the myocardium. The floppy mitral valve, for example, 
reflects an abnormality in the type I/III collagen ratio that 
may also be present in the matrix as well. At present, such a 
defect is thought to be confined to the valve leaflets, or the 
exteriorized portion of the network. This may not be the 
case. The involvement of the matrix could explain why some 
patients with degenerative mitral valve disease do not have a 
satisfactory response to valve replacement. The importance 
of preserving the structural integrity of the mitral valve 
apparatus-matrix network during surgical repair of the dis- 
eased mitral valve has recently been emphasized (24,25). 
The valves, chordae tendineae and collagen matrix of the 
myocardium consist primarily of jibrillar type I and 111 
collagens (22,26,27). The extracellular matrix of muscle is 
subdivided into epi-, peri- and endomysial components 
(28,29). Recent studies by Eghbali et al. (30,31), using cDNA 
probes specific for these collagens and in situ hybridization, 
indicate that in the myocardium cardiac fibroblasts, not 
myocytes, are responsible for the production of type I and 
III collagens. Cardiac fibroblasts are also likely to produce 
the proteolytic enzyme collagenase that is responsible for 
collagen degradation (32). Therefore, it must be recognized 
that disorders of cardiac fibroblasts, the cells involved in 
collagen synthesis and degradation, may result in interstitial 
heart disease (see later). Hence, and despite the importance 
of the contractile element, or cardiac myocyte, cardiac 
fibroblasts will undoubtedly come to be recognized as play- 
ing an important role in the appearance and progression of 
cardiovascular disease as well as in the regression of myo- 
cardial fibrosis. 
Components of the collagen matrix. The epimysium is the 
collagenous matrix that lies below the endothelium of the 
epicardium and endocardium; its surrounds the myocar- 
dium. Figure 2 depicts the various components of the matrix 
including the epimysium. The epimysium forms a complex 
array of collagen fibers that covers muscle (left panel, Fig. 
3). Robinson et al. (20) found that once this array of 
epimysial fibers is aligned parallel to muscle with stretch 
(right panel. Fig. 3), an exponential rise in passive muscle 
tension occurs with additional increments in muscle length. 
Hence, the epimysium resembles a parallel elastic element 
that resists and modulates compressive forces and that 
preserves the sarcomeric unit from excessive and disruptive 
degrees of stretch. The epimysium is an important determi- 
nant of the maximal length of papillary muscle. 
The perimysium consists of tendon-like extensions of the 
epirrrysiam (Fig. 2) that arborize into a weave to aggregate 
myocytes into myofibers. Perimysial strands of collagen, 
located in natural spaces between muscle bundles, join 
adjacent weaves (Fig. 3). Shearing forces. present between 
contracting muscle bundles, are borne by these strands. 
Given that the tensile strength of type I collagen exceeds that 
of steel (33). perimysial strands are well suited to accommo- 
date these forces and to minimize the dissipation of force 
generated by myocytes. Collagen fiber tensile strength is 
proportional to fiber thickness (5). It therefore follows that 
thicker collagen strands would permit a more powerful 
contraction of the myocardium. Furthermore. and because 
perimysial strands provide lateral connections between myo- 
cyte bundles. they prevent the malalignment or slippage of 
cardiac muscle. An absence of disruption of these strands 
would permit slippage that is necessary for the concentric or 
eccentric remodeling of the myocardium. Weaving through 
perimysial strands, in a direction parallel to muscle, are 
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broad collagen fibers or tendons (Fig. 4). Coiled perimysial 
fibers also run parallel to muscle fibers. Robinson et al. (21) 
have shown that these coiled perimysial fibers are continu- 
ous with chordae tendineae. 
Endomysial collagenjbers consist offibrils that connect 
adjoining myocytes to one another and to their neighboring 
capillaries (left panel, Fig. 5), and to a meshwork of fibrils 
that surround individual myocytes. The endomysial fibers 
connecting cells have been termed struts by Borg and 
Caulfield (2). Struts insert into the basal lamina lateral to the 
Z band of the sarcomeric unit (34) (right panel, Fig. 4). Inside 
the cell they may communicate with the cytoskeleton that 
supports the actin-myosin contractile protein apparatus (35) 
and that also may influence myocyte stiffness. Thus, one can 
envisage that these struts join together the contractile appa- 
ratus of adjacent cells. These lateral cell to cell connections 
further serve to coordinate the transduction of force to the 
ventricular chamber and to prevent cell slippage during the 
cardiac cycle. Winegrad and Robinson (36) showed that, 
even in the absence of the intercalated disc, cardiac muscle 
fibers contract in a coordinated manner because of these 
collagen tethers. Factor and Robinson (37) suggested that 
the forceful contraction and relengthening of the myocar- 
dium are related to the presence of intercellular tethers and 
the endomysial weave. In this connection, Iwazumi and ter 
Keurs (38) noted that the restoring force seen in cardiac 
tissue was diminished in isolated cardiac myocytes prepared 
with collagenase. 
Fibrillar type I and III collagens. On the basis of electro- 
phoretic analysis, the myocardium of the rat (26) and of the 
nonhuman primate (27) contains type I and III collagens. 
The collagen matrix consists primarily of type I collagen 
Figure 2. Schematic representation of the 
collagen matrix of the myocardium and its 
epimysial, perimysial and endomysial com- 
ponents (see text). (Reproduced with per- 
mission from Weber et al. [6].) 
Fieure 3. Silver-stained enimysial collagen fibers in the normal rat 
pa$llary muscle. A, Unstretched muscle, where collagen fibers 
have a complex arrangement. B, Stretched muscle and epimysial 
fibers now arranged parallel to muscle fibers (arrow). Additional 
stretch is now associated with an exponential increase in muscle 
tension. (Reproduced with permission from Robinson et al. [20].) 
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Figure 4. Normal human myocardium stained with Sir- 
ius Red and viewed by polarization microscopy. A, 
Coiled thick perimysial fibers (yellow or yellow-red) 
coursing between rows of organized muscle are seen. 
Collagen strands (arrows) connecting adjacent muscle 
fibers are quite evident. B, The nature of these strands 
is further identified (arrows). Note that the majority of 
collagen fibers are thick and appear yellow or yellow-red 
in color. The proportion of thin, green colored collagen 
fibers is quite small. (Reproduced with permission from 
Weber et al. 1121.) 
(85%); type III represents 11% of the total collagen protein. 
Valve leaflets contain 20% type III collagen (22). Type I 
collagen fibers have a substantial tensile strength (5,33). 
whereas type III collagen fibers possess a resilience that is 
ideal for maintaining structural integrity and distensibility of 
the network. Type I and III collagens are each thought to be 
present in most collagen fibers (39). 
Fibrillar type I collagen normally aggregates into pre- 
dominantly thickjbers, whereas type III collagen typically 
forms thinfibers 140). With use of the collagen specific stain, 
Sirius Red F3BA in a supersaturated picric acid solution, 
together with polarized light, an enhanced birefringence and 
differential coloration of thick and thin collagen fibers can be 
found (41,42). This histochemical technique has been used to 
distinguish the fibrillar nature of the collagen network 
(11,43-45) in normal and diseased myocardium. Immunohis- 
tochemical methods (34,46) using monospecific antibodies to 
type I and III collagens have indicated that endomysial 
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Figure 5. Endomysial collagen fibers between myocytes. Left 
panel, Scanning electron microscopy image of endomysial fibers or 
struts (St) seen in the nonhuman primate myocardium supporting 
myocytes (m) to one another and their capillaries (c). (Reproduced 
with permission from Weber et al. [3].) Right panel, Diagrammatic 
representation of endomysial fibrils (C) inserting near Z band of 
myocytes and communicating with intermediate filaments inside the 
cell. M = mitochondrion; My = myofilament. (Reproduced with 
permission from Robinson et al. [341.) 
Collagen synthesis and degradation. In studying mRNA 
to type I and III collagens in isolated cardiac cells and using 
the in situ hybridization technique in cultured cardiac cells 
and whole heart tissue, Eghbali et al. (30,31) found that 
fibroblasts, not myocytes, contain the message for these 
fibrillar collagens. Myocytes and fibroblasts contain the 
mRNA to type IV collagen. A remarkably ordered series of 
transcriptional, posttranscriptional and posttranslational 
events mark the biosynthesis of collagen and the formation 
of collagen fibrils. These events are reviewed elsewhere (47). 
Controversy exists as to whether fibrillogenesis actually 
occurs in fibroblasts, in the extracellular matrix, or in both. 
In the embryonic chick cornea, Birk and Trelstad (48) 
present evidence that fibrils of varying diameter are formed 
inside fibroblasts before they are deposited in the intersti- 
tium. They further demonstrate that fibroblasts control the 
direction in which fibrils are oriented. Once collagen fibrils 
are deposited in the extracellular matrix, they are cross- 
linked to create a very stable protein. Whether these findings 
apply to the heart remains to be elucidated. 
The daily fractional synthesis rate of collagen is 0.56% 
for the right and left ventricles of the dog (49) and 0.88% for 
the cockerel heart (50). Collagen half-life is estimated to be 
80 to 120 days. Therefore, myocardial collagen, whose 
synthesis rate is low relative to that of noncollagen protein, 
has a half-life 10 times longer. Moreover, and even though 
fibroblasts represent 70% of the heart’s total cell population 
(51), these cells are normally quiescent. 
Fibroblasts remain quiescent out of the cell cycle, or Go 
stage, until recruited back into the cell cycle when they can 
be stimulated to proliferate. The interaction of certain mito- 
genie agents or growth factors with cell surface receptors is 
fundamental to the regulation of fibroblast proliferation. In 
some cases a complex interaction of several growth factors 
is required to induce quiescent fibroblasts to proliferate (52). 
The addition of platelet-derived growth factor to quiescent 
cells, for example, initiates proliferation by making fibro- 
blasts “competent” to respond to the addition of other 
growth factors, termed “progression” factors. In keeping 
with this competence-progression model of fibroblast growth 
(53), cardiac fibroblasts residing in the interstitium would 
normally be exposed only to progression factors and there- 
fore are quiescent. It is not until competence factors are 
made available that these cells are able to proliferate. It 
remains to be determined whether cardiac fibroblasts strictly 
adhere to the competence-progression model. The various 
growth factors that contribute to this paradigm also remain 
to be elucidated. 
Collagen degradation in the myocardium has not been 
measured, but it would appear to be equivalent to synthesis, 
given the stability of its collagen concentration. Cardiac 
fibroblasts are again likely to be the cells responsible for 
degradation. Collagen fiber breakdown is mediated by col- 
lagenase. Montfort and Perez-Tamayo (54) identified colla- 
genase as residing in the perimysium and endomysium by 
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immunohistochemical labeling. Given that fibroblasts do not 
store this enzyme after it is formed, these findings suggest 
that the myocardium has a latent collagenase system. 
Whether this latent collagenase exists in either of its two 
known forms, as a zymogen or a tissue-inhibitor complex, 
remains to be elucidated (for review see Ref. 32). 
At present, the control and regulation of collagen genes 
and collagenase gene expression are unknown. These are 
particularly relevant topics if we are to prevent, retard or 
correct various forms of interstitial heart disease. 
Collagen Matrix Remodeling 
Pressure Overload Hypertrophy 
In ventricular hypertrophy that accompanies a volume 
overload state, such as an arteriovenous fistula or anemia. or 
after thyroxine administration, collagen concentration re- 
mains unchanged. This is not the case in various states of left 
ventricular pressure overload hypertrophy. where an in- 
crease in collagen concentration and a structural and bio- 
chemical remodeling of the collagenous matrix of the left 
ventricular myocardium are seen (for review see Ref. 3 and 
6). Thus it would appear that myocyte and collagen compart- 
ments are under separate as well as common controls. In 
both large and small mammalian hearts, banding of the 
ascending or abdominal aorta, coarctation of the renal 
artery, perinephritis and genetic hypertension are each as- 
sociated with collagen accumulation in the myocardium. 
This accumulation of collagen, which could also be termed 
fibrosis, should not be considered synonymous with myo- 
cyte necrosis in that cell loss need not be present. Further- 
more, although an elevation in left ventricular pressure work 
is common to each model, this elevation does not guarantee 
that systolic pressure itself is the stimulus to collagen 
synthesis and degradation. A number of putative mitogens 
may be operative depending on the etiologic basis of the 
pressure overload. 
In hamans with aortic vulve stenosis and symptomatic 
heurt failure (S-59), myocmrdial collagen concentration is 
increased three- to sixfold. Collagen volume fraction is also 
increased in patients with systemic hypertension: the greater 
the collagen accumulation, the more likely are patients to 
have symptomatic heart failure (60). 
Collagen synthesis and degradation. As already indicated, 
collagen synthesis is quite low (0.6%/day) relative to synthe- 
sis of noncollagenous protein (7.2%/day). After the induction 
of a pressure overload, noncollagenous protein synthesis 
increases promptly in the affected ventricular myocardium. 
By day 5, it is 75% greater than baseline (49,50), returning to 
control levels at the end of 2 weeks. The increase in collagen 
synthesis is slower, but more persistent. Protocollagen pro- 
line hydroxylase activity increases within days and is fol- 
lowed by enhanced radioactive proline incorporation into 
hydroxyproline (61.62). A six- to eightfold increase in colla- 
gen synthesis (4%/day) is seen. Collagen synthesis remains 
threefold greater than normal at 2 and 4 weeks (49). Auto- 
radiographic evidence of fibroblast proliferation reaches its 
peak several days after the rise in collagen synthesis (63,64). 
The relevance of these findings to the competence- 
progression model of fibroblast growth remains to be deter- 
mined. It can be said, however, that the rise in collagen 
synthesis is seen first in existing fibroblasts and is soon 
thereafter followed by fibroblast proliferation. At present, it 
is unclear if the population of fibroblasts responsible for 
collagen synthesis also participates in cell division. More- 
over, the signal and transducer that link the pressure over- 
load state to fibroblast proliferation remain to be determined. 
A rise in collagen synthesis is not seen in the unaflected 
,,entricle (49). This finding suggests that the release of local 
mitogens within the pressure-overloaded myocardium, the 
entry of putative mitogens into the interstitium of the in- 
volved myocardium or differences between ventricles are 
responsible for collagen accumulation. Circulating growth 
factors would be expected to alter collagen synthesis in both 
ventricles. Myocyte necrosis is not a requisite element for 
the appearance of reactive fibrosis. 
Biochemical studies suggest that collagen degradation 
also increases with the pressure overload, but returns to 
baseline more quickly than does the elevation in collagen 
synthesis (50). We found (27,43,44) morphologic evidence 
(see later) of collagenase activity, including disrupted colla- 
gen fibers. during the evolutionary phase of hypertrophy. 
The presence of collagen degradation would lower the 
absolute elevation in collagen concentration that is predicted 
solely on the basis of an elevation in collagen synthesis. 
Because the increase in myosin synthesis is more rapid 
than collagen synthesis, myocyte hypertrophy and a decline 
in both relative collagen content and concentration are seen 
early after pressure overload (49). Once myocyte growth 
stabilizes, although enhanced collagen synthesis persists and 
exceeds collagen degradation, collagen concentration and 
content will each increase to reach normal values within 
several weeks and greater than normal values at 4 weeks or 
more. 
New collagen formation and structural remodeling of ex- 
isting collagen. Caulfield (65) reported that with systemic 
hypertension the diameter of perimysial tendons and the 
density of the perimysial weave are increased in the hyper- 
trophied human myocardium. Studies conducted in our 
laboratory in the nonhuman primate with perinephritic hy- 
pertension (27,66) and in the rat with suprarenal abdominal 
aorta banding or perinephritis (44.45) revealed a similar 
morphologic pattern of remodeling. These studies also ex- 
tended our knowledge of the evolutionary and progressive 
nature of this remodeling and its functional consequences. 
In established hypertrophy, existing perimysial tendons, 
weaves and strands were greater in dimension (Fig. 6). A 
greater number of intermuscular spaces were now also 
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Figure 6. Scanning electron microscopy demonstrates the progres- 
sive increase in the dimension of the collagen matrix that is seen in 
the nonhuman primate myocardium with left ventricular pressure 
overload due to perinephritis. A, Normal myocardium and perimy- 
sial strands (arrow) between myocyte bundles. B, Thickened strands 
(arrow) are evident in hypertrophy. C, Normal myocardium with 
perimysial weave and tendons. D, Thickened tendons and dense 
weave seen with hypertrophy. 
occupied by newly formed perimysial fibers (Fig. 7). In 
addition to this interstitial fibrosis, a perivascular fibrosis 
was evident involving intramyocardial coronary arteries 
(67). From their location around arteries collagenous septa 
radiated outward into the intermuscular space between 
organized myofibers. This pattern of interstitial and perivas- 
cular fibrosis, also termed streaky fibrosis (68), represents 
one aspect of the structural remodeling of the interstitium in 
chronic pressure overload hypertrophy. 
Our studies also identified the evolution of the remodeling 
process. It began with evidence of collagen fiber degrada- 
tion, edematous-appearing intermuscular spaces and an in- 
creased formation of type III collagen. These findings had 
disappeared with the established phase of hypertrophy. This 
sequence, which resembles the early and late stages of 
dermal wound healing (69), was observed in both rat and 
primate myocardium. The mechanism responsible for the 
interstitial edema is not clear. It could be a response to an 
increased production of hydrophilic glycosaminoglycans 
(70), such as hyaluronic acid. In hypothyroidism, hyaluronic 
acid is increased in the myocardium and edema is frequently 
seen (71). In the case of myocyte injury, Judd and Wexler 
(72,73) found interstitial edema to accompany increased 
hexosamine formation. Alternatively, Laine (74) and others 
(75,76) have found coronary microvascular permeability to 
increase in response to either systemic hypertension or 
angiotensin infusion. Such an increase in permeability would 
cause interstitial edema. This issue is deserving of study 
because of its potential importance in developing preventive 
pharmacologic therapy. 
Additional patterns of structural remodeling. In estab- 
lished hypertrophy, we observed other structurally distinct 
patterns of myocardial fibrosis. One pattern was a reactive 
process and included a unique arrangement of type I and III 
collagen fibers that began as thin collagen fibers extending 
outward across muscle fibers, perpendicular to their long 
axis. Thick collagen fibers, running in a direction parallel to 
muscle and perpendicular to the thin collagen fibers, subse- 
quently became entwined in an ever increasing amount to 
form an orthogonal grid of thin and thick collagens fibers. 
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Figure 7. Picrosirius-polarization technique in the 
hypertrophied nonhuman primate myocardium. Top 
panel, Heavy perimysial tendons are found in a 
greater number of intermuscular spaces. Original 
magnification x 100, reduced by 24%. Middle panel, 
A second pattern of fibrosis consists of an orthogonal 
grid of thick and thin collagen fibers that envelop 
muscle fibers. Note that thin (green) collagen fibers 
cross over muscle at nearly right angles and are 
entwined by thick (yellow) collagen fibers at right 
angles. Original magnification x 100, reduced by 
26%. Lower panel, Another orthogonal grid, 90 
different from that seen in the middle panel, is seen in 
response to cell loss. Note that the thick (yellow) 
collagen fibers cross between muscle fibers at nearly 
right angles and are entwined by thin (green) colla- 
gen fibers at right angles. Original magnification 







Figure 8. Systolic and diastolic stress-strain relations are shown for 
the normal myocardium and under conditions where systolic and 
diastolic stiffness are altered concordantly (left) or discordantly 
(right) in the hypertrophied ventricle as collagen concentration 
increases and its alignment with cardiac muscle becomes abnormal; 
see text for discussion. L/LO = end-diastolic fiber length normal- 
ized to its unstretched length at zero filling pressure: SV = stroke 
volume. 
This grid (Fig. 7) begins to surround muscle fibers and will 
eventually envelop them. 
We have been able to evoke this pattern of perimuscular 
fibrosis in the rat using isoproterenol in small doses and have 
monitored the sequence of its formation over 8 days (43). 
The resultant orthogonal grid of collagen fibers resembles 
that seen with long-standing hypertension. 
Late in established hypertrophy, cell loss is evident and 
accompanied by a reparativejbrosis. Here the fibrous tissue 
formation also resembled an orthogonal grid of thick and thin 
collagen fibers. In this case, however, the grid is 90” different 
from the reactive fibrosis described before (Fig. 7). The 
replacement scar consists of thick collagen fibers that run 
perpendicular to muscle fibers now adjacent to one another 
and into which thin collagen fibers are entwined, followed 
subsequently by thicker collagen fibers. In studying discrete 
regions of replacement fibrosis that accompanies coronary 
microsphere embolization, we (77) found that short, thick, 
taut collagen fibers, bridging the void left by cell loss, were 
arranged in series with viable muscle. 
Functional consequences of collagen remodeling. In con- 
sidering the impact of collagen accumulation and remodeling 
on myocardial stiffness, the systolic and diastolic stress- 
strain relations of the intact ventricle were examined 
(27,44,45,77). In the established phase of hypertrophy in the 
rat, when collagen volume fraction had risen significantly 
from normal (3% to 5%) to occupy 8% to 12% of the 
myocardium, systolic stiffness and diastolic stiffness at 
larger strains were each increased (Fig. 8). This concordant 
increase in stiffness could not be attributed to a conversion 
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of myosin isoforms (67). On the other hand, the increase in 
force generation, a useful adaptation in the pressure- 
overloaded myocardium, could be related to the increased 
dimension and number of interfascicular perimysial strands. 
These strands served to reduce the dissipation of myocyte- 
generated force and to preserve stroke volume. The in- 
creased dimension of the parallel elastic-like elements, rep- 
resented by the perimysial weave and tendons, served to 
increase diastolic stiffness. Thus, with interstitial fibrosis, 
the increment in systolic and diastolic stress-strain relations 
would be expressed clinically as diastolic left ventricular 
dysfunction with a preservation of systolic function. This 
represents one form of pathologic hypertrophy. 
For greater increments in collagen volume fraction, 
representing up to 2070 or more of the hypertrophied myo- 
cardium, an increment in diastolic stiffness ut all strains was 
evident. For this degree of fibrosis, invoked experimentally 
by isoproterenol, systolic stiffness declined (Fig. 8). This 
discordant response between diastolic and systolic stiffness 
was related to the appearance of a fibrous meshwork that 
surrounded myocytes and that served to retard length- 
dependent myocyte force generation. Thus, when interstitial 
fibrosis is combined with perimuscular fibrosis, both dias- 
tolic and systolic left ventricular dysfunction will be evident. 
This is another form of pathologic hypertrophy. 
The reparative fibrosis accompanying coronary micro- 
sphere embolization, characterized by the in series addition 
of collagen to muscle, led to an increment in diastolic 
stiffness at larger strains. This has been termed the fibrosis 
type of decreased myocardial distensibility (78). It repre- 
sents yet another expression of pathologic hypertrophy. For 
the degree of cell loss obtained in this experimental model, 
systolic stiffness was sustained and even increased. We 
would expect, however, that when a large (e.g., 40%) 
portion of myocardium was lost, active stiffness would 
decline. 
Collectively, these studies of collagen structure and myo- 
cardial stiflness emphasize that it is not solely the amount of 
myocardium occupied by collagen, but the structural char- 
acteristics and arrangement of collagen fibers with respect to 
myocytes that influence the mechanical behavior of the 
myocardium. Moreover, the structural remodeling of colla- 
gen can account for the appearance of pathologic hypertro- 
phy with various expressions of diastolic and systolic left 
ventricular dysfunction. 
Further evidence in support of the role of collagen in 
altering myocardial stiffness has been obtained from other 
studies. In the hypertrophy that accompanies thyroxine 
administration (79), myocardial collagen concentration and 
cardiac muscle stiffness are each unchanged from normal. 
The increase in myocardial collagen concentration and the 
expected increase in diastolic stiffness seen in aorta-banded 
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animals are not seen when rats are pretreated with a lathyro- 
gen (80). 
Ischemic Heart Disease 
Cell loss. Reparative or replacement scarring of necrotic 
myocardium is a well recognized, long-term adaptation that 
maintains the structural integrity of the ventricle in the 
absence of myocytes, especially because muscle cells cannot 
regenerate. The early aspects of collagen matrix remodeling 
in response to cell loss was examined by Sato et al. (81), who 
followed the structural remodeling of the collagen matrix 
after 20, 40 and 120 min of coronary occlusion in the pig. 
Using scanning electron microscopy, they found a progres- 
sive disruption of collagen fibers appearing by 20 min in the 
subendocardium. Glycopro!eins began to disappear by 40 
min, whereas epimysial fibers and endomysial struts had 
disappeared at 2 h. In the absence of this restraint, sarco- 
mere lengths in these regions of the myocardium increased 
to 3.6 pm, which is likely the result of dyskinetic wall 
motion. These findings again underscore the protective role 
of epimysial fibers in resisting deformation and sarcomeric 
overdistension. They also suggest the presence of collage- 
nase activation with prolonged ischemia. The early disrup- 
tion of collagen fibers in the infarct zone was not seen in 
irradiated animals made leukopenic before coronary artery 
ligation (82). suggesting that either inflammatory cell- 
released collagenase or mononuclear cell-fibroblast interac- 
tion (32) to produce collagenase may be contributory to 
collagen degradation in this setting. 
The early inflammatory response and alterations in col- 
lagen metabolism to myocardial cell loss were monitored by 
Judd and Wexler (72,73) in the dog. Myocardial edema and 
enhanced glycosaminoglycan formation was observed for 
the first 5 days after cell loss and resolved thereafter. 
Cellular infiltration including fibroblasts was at its peak on 
day 3. Protocollagen proline hydroxylase activity increased 
on day 1, reaching a peak by day 3, whereas hydroxyproline 
concentration had increased significantly in necrotic regions 
by day 5 and continued to increase until day 12, after which 
it remained stable. The early increase in collagen synthesis 
before fibroblast proliferation suggests that collagen synthe- 
sis in existing fibroblasts was first to increase. Subsequently, 
a greater number of metabolically active fibroblasts contrib- 
ute to enhanced collagen formation. 
Over a 6 week period after myocardial infarction, the 
collagen concentration in the infarcted segment rises pro- 
gressively to 5 times its normal value (83). In noninfarcted 
regions, collagen concentration is unchanged. The accumu- 
lation of collagen leads to a progressive contraction of the 
infarct zone. The ventricular chamber, on the other hand, 
can increase in size over this interval, particularly if the 
infarction is large. Pfeffer et al. (84) found a progressive 
enlargement in left ventricular chamber size and filling 
Eccentric Hypwtrophy 
Dllatod Cardiopathy ,/’ 
Figure 9. Negative muscle fiber slippage and wall thinning in di- 
lated cardiopathy requires that collagen tethers be disrupted. 
volume 1 year after an anterior myocardial infarction. The 
mechanism or mechanisms responsible for this progressive 
dilation remain speculative. 
Stunned myocardium. “Stunned” myocardium is the 
term used to describe viable myocardium that has been 
salvaged by reperfusion, but in which there is transient, 
postischemic contractile dysfunction. Implicit in the term is 
the recovery of myocytes that are not irreversibly injured. 
Zhao et al. (1 i), using scanning and high voltage transmis- 
sion electron microscopy, have examined the structural 
integrity of fibrillar collagen in a coronary artery occlusion- 
reperfusion model of stunned myocardium. Implantable so- 
nomicrometer crystals were used to assess regional myocar- 
dial architecture and shortening. In this canine model of 
ischemia and reperfusion, the paradoxic expansion and 
thinning of the involved myocardium were accompanied by 
the degradation of collagen fibers and the loss of their 
structural integrity. Oxygen metabolites or free radicals, 
acting like a disulfide agent, a known activator of the latent 
collagenase-tissue inhibitor complex (32), may have caused 
collagen fiber breakdown. Caulfield et al. (85) recently 
showed that an infusion of the disulfide agent oxidized 
glutathione can cause collagen fiber disruption in the myo- 
cardium. Collagenase deactivation, by free radical scaven- 
gers having sulfhydryl groups, might accelerate the return in 
contractile function of the stunned myocardium. This area is 
deserving of study given that it could extend our pharmaco- 
logic concepts of cardioprotection and interventional cardi- 
ology. It is of further interest to note the occurrence of 
ventricular rupture soon after reperfusion with streptokinase 
(86) and that this may be prevented with beta-adrenergic 
blockade (87). Even though the current dictum “time is 
muscle” is pervasive, the salvage of myocytes with reperfu- 
sion techniques must be carried out within the context of 
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Given the importance of collagen and elastin in maintain- 
ing structural integrity and resilience of the heart and vas- 
culature, it is not unexpected that genetic disturbances in 
type I or type III collagen formation or elastin would be 
associated with structural defects of heart valves and blood 
vessels, respectively. Less well appreciated are the potential 
abnormalities of the collagen matrix that may involve the 
myocardium in these disorders. In this connection, the 
utility of pharmacologic agents that may prevent or retard 
blood vessel rupture or heart valve deformation have not 
been systemically examined. 
Ehlers-Danlos and Marfan syndromes. Various sub- 
classes of the Ehlers-Danlos syndrome, having autosomal 
dominant or recessive patterns of expression (88), have 
enhanced blood vessel fragility that may eventuate in rup- 
ture. The responsible biochemical defect is either unknown 
or proposed to be reduced synthesis of type III collagen that 
may compromise blood vessel resilience. 
In Marfan’s syndrome, aortic aneurysm and dissection 
and mitral valve prolapse are found. The nature of altered 
collagen biosynthesis or fiber formation is not entirely clear. 
Defects in cross-linking, the quality or quantity of the alpha 
chains in type I collagen, or elastin fibrillogenesis have each 
been proposed (see Ref. 22 and 88 for review). 
Mitral valve prolapse. The results of studies that exam- 
ined the relative proportions and synthesis of type I and III 
collagens have yielded conflicting results (for review see 
Ref. 22). An increase in type III collagen synthesis has been 
associated with redundant mitral valves, and may account 
for their poor tensile strength and increased resilience. In 
degenerative valve disease, a complete absence or decreased 
amount of type III collagen has been observed as is the case 
in patients with mitral valve prolapse and cerebral aneu- 
rysm. Given the prevalence of mitral valve prolapse, ac- 
quired and congenital defects in tissue collagen are likely to 
be found. 
Idiopathic (dilated) Cardiopathy 
The normal perimysial strands of the human myocardium 
are shown in Figure 4. It has been our contention that an 
absence or disruption of these muscle bundle to muscle 
bundle tethers would permit cardiac muscle fiber slippage, 
fiber realignment and wall thinning (Fig. 9). In addition, 
because its tensile strength would be reduced, the myocar- 
dium cannot resist deformation. As a result, the ventricles 
dilate and the left ventricular chamber becomes spherical as 
intracavitary stress becomes equal in all directions. In post- 
mortem human hearts, each of which had previously been 
shown (89) to have abnormal thinning and spherical config- 
uration of the ventricle, we observed (12) the following (Fig. 
10): 1) collagen tethers were markedly reduced in number; 
perimysial strands either were present but disrupted, or were 
absent; and 2) an excess proportion of thin collagen fibers, 
perhaps representing type III collagen, was observed by the 
polarized light and picrosirius red technique. These findings 
have led us (12) to propose the term cardiopathy, and to 
reasonably expect that a spectrum of interstitial heart dis- 
ease of diverse etiology will be found to account for some 
cases of primary myocardial disease. 
Senescent Myocardium 
Intermolecular cross-linking of collagen increases with 
age. This occurs in heart valves (90) and myocardium (91) 
and ‘serves to retard collagen degradation by collagenase. 
Hence, there is an increase in the concentration of insoluble 
collagen. The collagen concentration of the senescent myo- 
cardium has been reported to be either increased (92-94), 
particularly in the subendocardium, or unchanged (95,96). In 
the senescent Fischer 344 rat (97) and Wistar rat (98), the 
accumulation of collagen within the subendocardium in- 
creases muscle stiffness. On the basis of the alignment of 
collagen and muscle, the accumulation of collagen can alter 
myocyte loading, as noted earlier for chronic left ventricular 
pressure overload. Encircled by fibrillar collagen, muscle 
may not be stretched and, therefore, myocyte work is 
reduced (45). Unloaded, myocytes become atrophic (99). 
Elsewhere in the myocardium and near the periphery of 
fibrous tissue, loading of myocytes may be increased, lead- 
ing to their hypertrophy. This hypothesis remains to be 
rigorously examined, but may provide one explanation for 
the prevalence of left ventricular hypertrophy in the elderly 
(99). The mechanism responsible for endomyocardial fi- 
brosis in the senescent myocardium is unclear. Specific 
abnormalities in fibroblast-mediated collagen synthesis or 
degradation, subendocardial perfusion or permeability of the 
endothelial surface of the endomyocardium need to be 
examined. 
Future Directions 
It is now appreciated that the myocardium contains a 
collagen matrix that is a major determinant of its architec- 
ture, structural integrity and mechanical properties. This 
fibrillar matrix consists primarily of type I and III collagens 
having epimysial, perimysial and endomysial components. 
The interrelations among the morphologic features of these 
components, their biochemical characteristics and biophys- 
ical properties and the function they serve, need to be 
further refined. The same holds true for the various patterns 
of myocardial fibrosis that have been observed in pressure 
overload hypertrophy. These structure-function correlations 
will serve to decipher abnormalities in diastolic and systolic 
stiffness, target collagenolytic therapy for a reactive fibrosis 
associated with impaired ventricular function and aid in our 
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understanding of disorders of collagen synthesis, type I or 
III collagen formation, fibrillogenesis and defective or exces- 
sive collagen degradation. 
Future studies of collagen and collagenase gene regula- 
tion and collagen biosynthesis and degradation in the heart, 
together with the mechanisms operative in the regulation of 
cardiac fibroblast proliferation, are necessary elements to 
fully elucidate the role of the cardiac interstitium in health 
and disease. Interstitial heart disease is an entity that em- 
braces primary or secondary abnormalities of the cardiac 
interstitium and its structural, immunologic and nutritional 
functions. For example, excess, abnormal or inadequate 
fibrillar collagen represent structurally based expressions of 
this hitherto unrecognized entity. The etiologic factors that 
lead to disorders of the collagen matrix, and which, in turn, 
lead to a compromise in the mechanical properties of the 
myocardium, require recognition and systematic investiga- 
tion. These will be accomplished through the coordinated 
efforts of basic and applied scientists and the integration of 
advances from the molecular and cell biology laboratory into 
pathophysiologic and clinical expressions of cardiovascular 
disease. In so doing, it will be possible to enter the 21st 
century armed with corrective forms of therapy, targeted at 
the remodeled interstitium. 
References 
1. Weber KT, Janicki JS, Hunter WC, Shroff SG, Pearlman ES, Fishman 
AP. The contractile behavior of the heart and its functional coupling to 
the circulation. Prog Cardiovasc Dis 1982;24:375-400. 
2. Borg TK, Caulfield JB. The collagen matrix of the heart. Fed Proc 
1981;40:2037-41. 
3. Weber KT, Janicki JS, Pick R, et al. Collagen in the hypertrophied 
pressure-overloaded myocardium. Circulation 1987;75(suppl ):I-40-7. 
4. Robinson TF, Factor SM, Sonnenblick EH. The heart as a suction 
pump. Sci Am 1986;254:w91. 
5. Parry DAD, Craig AS. Collagen fibrils during development and matura- 
tion and their contribution to the mechanical attributes of connective 
tissue. In: Nimni ME, ed. Collagen. Boca Raton: CRC Press, 1988;2:1- 
23. 
6. Weber KT, Clark WA, Janicki JS, Shroff SG. Physiologic versus 
pathologic hypertrophy and the pressure-overloaded myocardium. J 
Cardiovasc Pharmacol 1987;1O(suppl 6):S37-49. 
7. Weber KT, Janicki JS, Shroff SG, et al. Collagen compartment remod- 
eling in the pressure overloaded left ventricle. J Appl Cardiol 1988;1:37- 
46. 
8. Dawson R, Mime G, Williams RB. Changes in the collagen or rat heart 
in copper-deficiency-induced cardiac hypertrophy. Cardiovasc Res 1982; 
16:55%5. 
9. Factor SM, Robinson TF, Dominitz R, Cho S. Alterations of the 
myocardial skeletal framework in acute myocardial infarction with and 
without ventricular rupture. Am J Cardiovasc Pathol 1986;1:91-7. 
10. Turto H, Lindy S, Halme J. Protocollagen proline hydroxylase activity 
in work-induced hypertrophy of rat muscle. Am J Physiol 1974;226:63- 
5. 
12. Weber KT, Pick R, Janicki JS, Gadodia G, Lakier JB. Inadequate type 
I collagen tethers in dilated cardiopathy. Am Heart J 1988;116: 1641-6. 
13. Holmgren E. Ueber die Trophospongien des quergestrieften Muskel- 
fasem, nebst Bemerkungen ueber den allgemeinen Bau dieser Fasem. 
Arch Mikrosk Anat 1907;71:165-201. 
14. Nagle E. Die mechanischen Eigenschaften von Perimysium internum 
und Sarkolemm bei den quergestreiften MuskeIfasern. Z Zehforsch 
Mikrosk Anat 1935;22:694-706. 
15. Hort W. Untersuchungen zur funktionellen Morphologie des Bind- 
egewebsgerustes und der Blutgefasse der linken Herzkammerwand. 
Virchows Arch Path Anat 1960;333:565-81. 
16. Fry DL, Griggs DM, Greenfield JC. Myocardial mechanics: tension- 
velocity-length relationships of heart muscle. Circ Res 1964;14:73-85. 
17. Hefner LL, Bowen TE. Elastic components of cat papillary muscle. Am 
J Physiol 1%7;212:1221-7. 
18. Caspari PG, Gibson K, Harris P. Changes in myocardial collagen in 
normal development and after pblockade. Ret Adv Card Struct Metab 
1976;7:99-104. 
19. Zak R. Cell proliferation during cardiac growth. Am J Cardiol 1973;31: 
211-9. 
20. Robinson TF, Cohen-Gould L, Factor SM. The skeletal framework of 
mammalian heart muscle: arrangement of inter- and pericellular connec- 
tive tissue structures. Lab Invest 1983;49:482-7. 
21. Robinson TF, Geraci MA, Sonnenblick EH, Factor SM. Coiled perimy- 
sial fibers of papillary muscle in rat heart: morphology, distribution, and 
changes in configuration. Circ Res 1988;63:577-92. 
22. Bashey RI, Jimenez SA. Collagen in Heart Valves. In: Ref. 5:1:257-74. 
23. Hansen DE, Cahill PD, DeCampli WM, et al. Valvular-ventricular 
interaction: importance of the mitral apparatus in canine left ventricular 
systolic performance. Circulation 1986;73:1310-20. 
24. David TE, Ho WC. The effect of preservation of chordae tendineae on 
mitral valve replacement for postinfarction mitral regurgitation. Circu- 
lation 1986;74(suppl 1):1-l 16-20. 
25. Salter DR, Pellom GL, Murphy CE, et al. Papillary-annular continuity 
and left ventricular systolic function after mitral valve replacement. 
Circulation 1986;74(suppl I)+121-9. 
26. Medugorac I, Jacob R. Characterization of left ventricular collagen in 
the rat. Cardiovasc Res 1983;17:15-21. 
27. Weber KT, Janicki JS, Shroff SG, Pick R, Chen RM, Bashey RI. 
Collagen remodeling of the pressure overloaded, hypertrophied nonhu- 
man primate myocardium. Circ Res 1988;67:757-65. 
28. Rowe RWD. Morphology of perimysial and endomysial connective 
tissue in skeletal muscle. Tissue Cell 1981;13:681-90. 
29. Borg TK, Caulfield JB. Morphology of connective tissue in skeletal 
muscle. Tissue Cell 1980;12:197-207. 
30. Eghbali M, Czaja MJ, Zeydel M, Weiner FR, Seifter S, Blumenfeld 00. 
Collagen mRNAs in isolated adult heart cells. J Mol Cell Cardiol 
1988;20:267-76. 
31. Eghbali M, Blumenfeld 00, Seifter S, et al. Localization of types I, III, 
and IV collagen mRNAs in rat heart cells by in situ hybridization. J Mol 
Cell Cardiol 1989;21:103-13. 
32. Woolley DE. Mammalian collagenases. In: Piez KA, ed. Extracellular 
Matrix Biochemistry. New York: Elsevier, 1984: 119-57. 
33. Burton AC. Relation of structure to function of the tissues of the wall of 
vessels. Physiol Rev 1954;34:619-42. 
34. Robinson TF, Factor SM, Capasso JM, Wittenberg BA, Blumenfeld 00. 
Morphology, composition, and function of struts between cardiac myo- 
cytes of rat and hamster. Cell Tissue Res 1987;249:247-55. 
11. Zhao M, Zhang H, Robinson TF, Factor SM, Sonnenblick EH, Eng C. 
Profound structural alterations of the extracellular collagen matrix in 
postischemic dysfunctional (“stunned”) but viable myocardium. J Am 
Coil Cardiol 1987;lO: 1322-34. 
35. Price MG. Molecular analysis of intermediate filament cytoskeleton: a 
putative load-bearing structure. Am J Physiol 1984;15:H566-72. 
36. Winegrad S, Robinson TF. Force generation among cells in the relaxing 
heart. Eur J Cardiol 1978;7:63-70. 
JACC Vol. 13, No. 7 
June 1989: 1637-52 
WEBER 1651 
CARDIAC INTERSTITIUM 
37. Factor SM, Robinson TF. Comparative connective tissue structure: 






















twazumi T, ter Keurs HEDJ. Mechanical properties of single cardiac 
myocytes and ultra small trabeculae of rat (abstr). Circulation 1987: 
76(suppI IV):IV-331. 
Keene DR, Sakai LY, Bachinger HP, Burgeson RE. Type III collagen 
can be present in banded collagen fibrils regardless of fibril diameter. J 
Cell Biol 1987;105:2393-402, 
Montes GS, Junqueira LCU. Biology of collagen. Rev Can Biol Exp 
1982;41:143-56. 
Junqueira LCU, Copssermelli W, Brentani R. Differential staining of 
collagens type I, II, and III by Sirius red and polarization microscopy. 
Arch Histol Jpn 1978;41:267-74. 
Junqueira LCU, Bignolas G, Brentani RR. Picrosirius staining plus 
polarization microscopy, a specific method for collagen detection in 
tissue sections. Histochem J 1979;11:447-55. 
Pick R, Jalil JE, Janicki JS, Weber KT. The tibrillar nature and structure 
of isoproterenol-induced myocardial fibrosis in the rat. Am J Pathol 
1989;134:365-71. 
Doering CW, Jalil JE, Janicki JS, et al. Collagen network remodeling and 
diastolic stiffness of the rat left ventricle with pressure overload hyper- 
trophy. Cardiovasc Res 1988;22:686-95. 
Jalil JE, Doering C, Pick R, Shroff S, Weber KT. Fibrillar collagen and 
myocardial stiffness in the intact hypertrophied rat left ventricle. Circ 
Res (in press). 
Robinson TF, Cohen-Gould L, Factor SM, Eghbali M. Blumenfeld 00. 
Structure and function of connective tissue in cardiac muscle: collagen 
types I and III in endomysial struts and pericellular fibers. Scanning 
Electron Microsc 1988;2:1005-15. 
Nimni ME, Harkness RD. Molecular structure and functions of collagen. 
In: Ref. 5:1:3-77. 
Birk DE, Trelstad RL. Extracellular compartments in matrix morpho- 
genesis: collagen tibril, bundle, and lamellar formation by cornea1 
tibroblasts. J Cell Biol 1984;99:2024-33. 
Bonnin CM, Sparrow MP, Taylor RR. Collagen synthesis and content in 
right ventricular hypertrophy in the dog. Am J Physiol 198l;lO:H703-13. 
Laurent GJ. Sparrow MP, Bates PC, Millward DJ. Collagen content and 
turnover in cardiac and skeletal muscles of the adult fowl and the 
changes during stretch-induced growth. Biochem J 1978;176:419-27. 
Grove D. Zak R, Nair KG, Aschenbrenner V. Biochemical correlates of 
cardiac hypertrophy. IV. Observations on the cellular organization of 
growth during myocardial hypertrophy in the rat. Circ Res 1969;25:473- 
85. 
Rosengurt E. Early signals in the mitogenic response. Science 1986;234: 
161-6. 
Villereal ML, Mix-Muldoon LL, Vicentini LM, Jamieson GA, Owen 
NE. Mechanisms of growth factor stimulation of NA+-H’ exchange in 
cultured fibroblasts. Curr Top Membr Trans 1986;26:175-91. 
Montfort I, Perez-Tamayo R. The distribution of collagenase in normal 
rat tissues. .I Histochem Cytochem 1975;23:91&20. 
Schwarz F, Flameng W, Schaper J, Hehrlein F. Correlation between 
myocardial structure and diastolic properties of the heart in chronic 
aortic valve disease: effects of corrective surgery. Am J Cardiol 1978;42: 
895-903. 
Hess OM, Schneider J, Koch R, Bamert C, Grimm J, Krayenbuehl HP. 
Diastolic function and myocardial structure in patients with myocardial 
hypertrophy: special reference to normalized viscoelastic data. Circula- 
tion 1981;63:360-il. 
Caspari PG, Newcomb M, Gibson K, Harris P. Collagen in the normal 
and hypertrophied human ventricle. Cardiovasc Res 1977;11:554-8. 
Schaper J, Schaper W. Ultrastructural correlates of reduced cardiac 
function in human heart disease. Eur Heart J 1983;4(suppl A):35-42. 
59. Oldershaw PJ, Brooksby IAB, Davies MJ, Coltart DJ, Jenkins BS, 
Webb-Peploe MM. Correlations of fibrosis in endomyocardial biopsies 
from patients with aortic valve disease. Br Heart J 1980$4:609-l I. 
60. Pearlman ES, Weber KT, Janicki JS, Pietra G, Fishman AP. Muscle 
fiber orientation and connective tissue content in the hypertrophied 
human heart. Lab Invest 1982;46:158-64. 
61. Lindy S, Turto H, Uitto J. Protocoliagen proline hydroxylase activity in 
rat heart during experimental cardiac hypertrophy. Circ Res 1972;30: 
205-9. 
62. Turto H. Collagen metabolism in experimental cardiac hypertrophy in 
the rat and effect of digitoxin treatment. Cardiovasc Res 1977:11:358-66. 
63. Morkin E, Ashford TP. Myocardial DNA synthesis in experimental 
cardiac hypertrophy. Am J Physiol 1%8;215:1409-13. 
64. Skosey JL, Zak R, Martin AF. Biochemical correlates of cardiac 
hypertrophy. V. Labeling of collagen, myosin and nuclear DNA during 
experimental myocardial hypertrophy in the rat. Circ Res 1972;31:145- 
57. 
65. Caulfield JB. Alterations in cardiac collagen with hypertrophy. Perspect 
Cardiovasc Res 1983:8:49-57. 
66. Abrahams C. Janicki JS, Weber KT. Myocardial hypertrophy in macaca 
fasicularis: structural remodeling of the collagen matrix. Lab Invest 
1987;56:67f&83. 
67. Jalil JE, Doering C, Janicki JS, Pick R, Clark WA, Weber KT. Structural 
vs contractile protein remodeling and myocardial stiffness in hypertro- 
phied rat left ventricle. J Mol Cell Cardiol (in press). 
68. Thiedemann KU, Holubarsch C, Medugorac I, Jacob R. Connective 
tissue content and myocardial stiffness in pressure overload hypertro- 
phy. A combined study of morphologic, morphometric, biochemical and 
mechanical parameters. Basic Res Cardiol 1983;78: 140-55. 
69. Clore JN, Cohen IK, Diegelmann RF. Quantification of collagen types 1 
and III during wound healing in rat skin. Proc Sot Exp Bio Med 
1979:161:337-40. 
70. Dorfman AJ. Polysaccharides of connective tissue. J Histochem Cy- 
tochem 1983:11:2-13. 
71. von Knorring J. Analysis of myocardial mucopolysaccharies in hyper- 
and hypothyroid rats and guinea pigs. Ann Med Exp Biol Fenn 1970;48: 
8-15. 
72. Judd JT, Wexler BC. Myocardial connective tissue metabolism in 
response to injury. Histological and chemical studies of mucopolysac- 
charide and collagen in rat hearts after isoproterenol-induced infarction. 
Circ Res 1969;25:201-14. 
73. Judd JT, Wexler BC. Prolyl hydroxylase and collagen metabolism after 
experimental myocardial infarction. Am J Physiol 1975;228:2126. 
74. Laine GA. Microvascular changes in the heart during chronic arterial 
hypertension. Circ Res 1988;62:953-60. 
75. Giacomelli F, Anversa P, Wiener J. Effect of angiotensin-induced 
hypertension on rat coronary arteries and myocardium. Am J Pathol 
1976;84: I1 l-25. 
76. Bhan RD, Giacomelli F, Wiener J. Ultrastructure of coronary arteries 
and myocardium in experimental hypertension. Exp Mol Pathol 1978;29: 
66-81. 
77. Carroll E, Janicki JS, Pick R, Weber KT. Myocardial stiffness and 
reparative fibrosis following coronary embolization in the rat (abstr). J 
Am Coll Cardiol 1989:13(suppl A):lA. 
78. Holubarsch CH. Jacob R. Evaluation of elastic properties of myocar- 
dium. Experimental models of fibrosis and contractme in heart muscle 
strips. Z Kardiol 1979:68:123-7. 
79. Holubarsch CH. Holubarsch T, Jacob R. Medugorac I. Thiedemann K. 
Passive elastic properties of myocardium in different models and stages 
of hypertrophy: a study comparing mechanical, chemical and morpho- 
metric parameters. Perspect Cardiovasc Res 1983;7:323-36. 
80. Bing OHL, Fanburg BL, Brooks WW. Matsushita S. The effect of the 
lathyrogen p-amino proprionitrile (BAPN) on the mechanical properties 
1652 WEBER JACC Vol. 13, No. 7 
CARDIAC INTERSTITIUM June 1989: 3637-52 
of experimentally hypertrophied rat cardiac muscle. Circ Res 1978;43: 
632-l. 
81. Sato S, Ashraf M, Millard RW, Fujiwara H, Schwartz A. Connective 
tissue changes in early ischemia of porcine myocardium: an ultrastruc- 
90. Bashey RI, Torii S, Angrist A. Age-related collagen and elastin content 
of human heart valves. J Gerontol 1%7;22:203-8. 
91. Zwolinski RJ, Hamlin CR, Kohn RR. Age-related alteration in human 
heart collagen. Proc Sot Exo Bio Med 1976:152:362-5. 
tural study.-J Mol Cell Cardiol 1983;15:261-275. 
82. Cannon RO, Butany JW, McManus BM, et al. Early degradation of 
92. Lenkiewicz JE, Davies MJ, Rosen D. Collagen in human myocardium as 
a function of age. Cardiovasc Res 1972:6:549-55. 
collagen after acute myocardial infarction in the rat. Am J Cardiol 
1983;52:390-5. 
83. Jugdutt BI, Amy RWM. Healing after myocardial infarction in the dog: 
changes in infarct hydroxyproline and topography. J Am Coil Cardiol 
1986;7:91-102. 
84. Pfeffer MA, Lamas GA, Vaughan DE, Parisi AF, Braunwald E. Effect of 
captopril on progressive ventricular dilatation after anterior myocardial 
infarction. N Engl J Med 1988;319:80-6. 
85. Cauhield JB, Wolkowicz P. Inducible collagenolytic activity in isolated, 
oerfused rat hearts. Am J Pathol 1988:131:199-205. 
93. Tomanek RJ, Taunton CA, Liskop KS. Relationship between age, 
chronic exercise, and connective tissue of the heart. J Gerontol 1972;27: 
33-8. 
94. Pfeffer JM, Pfeffer MA, Fishbein MC, Froehlich ED. Cardiac function 
and morphology with aging in the spontaneously hypertensive rat. Am J 
Physiol 1979;6:H461-8. 
95. Kohn RR, Rollerson E. Age-changes in swelling properties of human 
myocardium. Proc Sot Exp Biol Med 1959;100:253-7. 
96. Montfort I, Perez-Tamayo R. The muscle collagen ratio in normal and 
86. GISSI. Ricerca del Gruppo Italian0 per lo Studio della Streptochinasi 
nell’Infarto Miocardico, Progetto generale e sottoprogetti. Risultati della 
fase acuta e de1 follow-up. G Ital Cardiol 1987;17:1-102. 
87. ISIS-1 (First International Study of Infarct Survival) Collaborative 
Grouo. Mechanisms for the earlv mortalitv reduction oroduced bv 
beta-blockade started early in acute myocardial infar&on: ISIS-<. 
Lancet 1988;i:921-3. 
hypertrophic human hearts. Lab Invest 1962;11:463-70. 
97. Anversa P, Puntillo E, Nikitin P, Olivetti G, Capasso JM, Sonnenblick 
EH. Effects of age on mechanical and structural properties of myocar- 
dium of Fischer 344 rats. Am J Physiol 1989 (in press). 
98. Weisfeldt ML, Loeven WA, Shock NW. Resting and active mechanical 
properties of trabeculae cameae from aged male rats. Am J Physiol 
1971;220:1921-7. 
88. Shamban A. Collagen alterations in heritable connective tissue disor- 
ders. In: Uitto J, moderator. Biochemistry of Collagen in Diseases. Ann 
Intern Med 1986;105:749-56. 
89. Weber KT, Janicki JS, Shroff S. Mechanical and structural aspects of the 
hypertrophied human myocardium. Perspect Cardiovasc Res 1983;8: 
201-10. 
99. Jalil JE, Janicki JS, Pick R, Abrahams C, Weber KT. Fibrosis-induced 
reduction of endomyocardium in the rat following isoproterenol. Circ 
Res 1989 (in press). 
100. Levy D, Anderson KM, Savage DD, Kannel WB, Christiansen JC, 
Castelli WP. Echocardiographically detected left ventricular hypertro- 
phy: prevalence and risk factors. Ann Intern Med 1988;108:7-13. 
